Internal Medicine

3151 questions

Question 521Question →

A 38-year-old woman is evaluated in the outpatient clinic for a 6-month history of profound fatigue, progressive generalized weakness, dry skin, and constipation. She also reports frequent lightheadedness, particularly when standing up quickly. The patient has not menstruated for the past 5 months, although she previously had regular cycles. Her last pregnancy was 4 years ago and was uncomplicated. She takes no medications and does not use illicit drugs. Her body mass index is 22 kg/m222 \text{ kg/m}^2. Vital signs show a blood pressure of 92/58 mm Hg92/58 \text{ mm Hg} while supine that drops to 80/50 mm Hg80/50 \text{ mm Hg} upon standing. Her heart rate is 58/min58/\text{min}. Physical examination reveals pale, dry skin and sparse axillary and pubic hair. The relaxation phase of the ankle reflexes is significantly delayed.

Laboratory studies show:
Hemoglobin: 11.2 g/dL11.2 \text{ g/dL}
Sodium: 132 mEq/L132 \text{ mEq/L}
Potassium: 4.1 mEq/L4.1 \text{ mEq/L}
Thyroid-stimulating hormone (TSH): 0.15 \muU/mL0.15 \text{ \mu U/mL} (normal: 0.4−4.0 \muU/mL0.4 - 4.0 \text{ \mu U/mL})
Free thyroxine (T4): 0.3 ng/dL0.3 \text{ ng/dL} (normal: 0.9−2.4 ng/dL0.9 - 2.4 \text{ ng/dL})

Which of the following additional laboratory findings is most likely present in this patient?

Show answer & explanation

Answer: Decreased serum morning cortisol

Answer

Decreased serum morning cortisol
The correct answer is decreased serum morning cortisol because the patient's presentation and laboratory findings are highly consistent with panhypopituitarism. The presence of a low free T4 along with an inappropriately low TSH confirms secondary (central) hypothyroidism. The concurrent symptoms of orthostatic hypotension, hyponatremia, amenorrhea, and loss of axillary and pubic hair point to multiple anterior pituitary hormone deficiencies, specifically adrenocorticotropic hormone (ACTH) and gonadotropins. The reduction in ACTH leads to secondary adrenal insufficiency, which is biochemically characterized by a decreased serum morning cortisol level.

Step-by-Step Solution

1
Interpret the thyroid function tests.
The patient has a low free T4 (0.3 ng/dL0.3 \text{ ng/dL}) with an inappropriately low TSH (0.15 \muU/mL0.15 \text{ \mu U/mL}), which points directly to secondary (central) hypothyroidism rather than a primary thyroid disorder.
In primary hypothyroidism, the low free T4 would trigger a loss of negative feedback, resulting in a markedly elevated TSH.
2
Correlate the central hypothyroidism with the rest of the clinical presentation.
The patient also has amenorrhea, orthostatic hypotension, mild hyponatremia, and loss of axillary/pubic hair, indicating involvement of the gonadal and adrenal axes.
Multiple hormone deficiencies (thyroid, gonadal, adrenal) of central origin confirm a diagnosis of panhypopituitarism.
3
Predict the expected laboratory values for the affected endocrine axes.
Because the anterior pituitary is failing, it cannot produce adequate adrenocorticotropic hormone (ACTH), leading to secondary adrenal insufficiency characterized by decreased serum morning cortisol.
Understanding the hypothalamic-pituitary-target organ axis allows one to anticipate that both the stimulating hormone (ACTH) and the target organ hormone (cortisol) will be low.

Key Concept

Patients presenting with secondary hypothyroidism (low free T4 and inappropriately low/normal TSH) frequently have concurrent deficiencies in other anterior pituitary hormones, known as panhypopituitarism, which typically manifests with secondary adrenal insufficiency (low cortisol, low/normal ACTH, normal aldosterone) and hypogonadotropic hypogonadism (low sex steroids, low/normal FSH/LH).
Estimated Time:1m 30s
Question 522Question →

Match each infectious exposure scenario with the most appropriate guideline-directed post-exposure prophylaxis or preemptive pharmacotherapy.

Click a left item, then click its matching right item

Items

A 34-year-old healthcare worker sustains a deep hollow-bore needle-stick injury from a patient positive for HIV and Hepatitis B surface antigen. The worker has documented protective Hepatitis B surface antibodies from prior vaccination.
A 26-year-old pregnant woman at 14 weeks gestation is identified as a close contact of a coworker who was recently hospitalized with confirmed meningococcal meningitis.
A 50-year-old man who underwent a renal transplant six months ago has significant face-to-face exposure to a nephew with active varicella. The patient is seronegative for Varicella-Zoster virus IgG.
A 22-year-old asymptomatic man presents to the clinic because his primary sexual partner developed a painless penile chancre 3 days ago. The patient's rapid plasma reagin (RPR) test is currently nonreactive.

Matches

Show answer & explanation

Answer

The healthcare worker requires HIV PEP (tenofovir-emtricitabine and raltegravir); the pregnant contact requires IM ceftriaxone; the transplant recipient requires VZIG; and the syphilis contact requires IM benzathine penicillin G.
Each scenario represents a specialized post-exposure prophylaxis protocol. Management must integrate the specific pathogen risks with critical host factors, such as established immunity, pregnancy, immunocompromised state, and the timing of exposure.

Step-by-Step Solution

1
Evaluate the healthcare worker's exposure to HIV and HBV.
Requires HIV PEP; protected against HBV.
Deep needle-sticks carry high HIV transmission risk requiring 3-drug PEP. Prior immunity to HBV (positive HBsAb) negates the need for HBIG or HBV vaccine boosters.
2
Assess the pregnant woman's exposure to N. meningitidis.
Requires prophylaxis with ceftriaxone.
Pregnancy restricts the use of standard PEP agents like ciprofloxacin or rifampin; ceftriaxone is the guideline-preferred safe alternative for meningococcal prophylaxis.
3
Analyze the transplant patient's exposure to varicella.
Requires Varicella-Zoster immune globulin (VZIG).
Immunocompromised hosts lacking VZV immunity are at extreme risk for life-threatening disseminated varicella and must receive passive immunization.
4
Determine the management for the syphilis contact with negative serology.
Requires empiric treatment with benzathine penicillin G.
Serologic tests (like RPR) may be falsely negative in incubating syphilis; high-risk exposure within 90 days warrants presumptive curative therapy.

Key Concept

Host-specific modifications of post-exposure prophylaxis and preemptive therapy for infectious diseases
Question 523Question →

A 38-year-old woman is evaluated in the outpatient clinic for progressive weight gain, proximal muscle weakness, and new-onset facial hair growth over the past 8 months. She takes no prescription or over-the-counter medications. Her temperature is 37.0°C (98.6°F), blood pressure is 158/98 mm Hg, pulse is 82/min, and BMI is 34 kg/m². Physical examination reveals facial plethora, a prominent dorsocervical fat pad, and wide, violaceous striae on the lower abdomen. Basic metabolic panel shows a serum potassium of 3.2 mEq/L and a fasting blood glucose of 145 mg/dL. The physician strongly suspects endogenous Cushing syndrome. Arrange the following diagnostic steps in the correct chronological sequence required to accurately diagnose and localize the etiology of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct diagnostic algorithm sequence is to first confirm hypercortisolism with a screening test, followed by measuring plasma ACTH to determine ACTH dependence, then performing a high-dose dexamethasone suppression test to localize the source, and finally obtaining targeted anatomical imaging such as a pituitary MRI.
The diagnostic algorithm for Cushing syndrome is strictly phased to prevent diagnostic error. It must begin with establishing the diagnosis of hypercortisolism via screening tests. Once confirmed, the next phase is determining ACTH dependence by measuring plasma ACTH. For ACTH-dependent disease, dynamic testing (such as high-dose dexamethasone suppression) is performed to separate pituitary from ectopic sources. Finally, anatomical imaging is directed strictly by the biochemical findings.

Step-by-Step Solution

1
Recognize the clinical signs of hypercortisolism (central obesity, plethora, striae, hypokalemia) and exclude exogenous glucocorticoid use.
Determine the need for a definitive diagnostic workup for endogenous Cushing syndrome.
Classic physical and laboratory findings warrant an algorithmic approach to prevent misdiagnosis.
2
Select a primary screening test (e.g., 24-hour urine free cortisol, late-night salivary cortisol, or overnight low-dose dexamethasone suppression test).
Confirm pathologically elevated systemic cortisol levels.
Endogenous hypercortisolism must be biochemically proven before attempting to uncover its etiology.
3
Measure plasma ACTH concentration.
Identify the primary category of Cushing syndrome.
ACTH levels dictate the algorithm's next branch: suppressed ACTH points directly to an adrenal tumor, while normal or high ACTH points to a central or ectopic source.
4
Perform a high-dose dexamethasone suppression test for ACTH-dependent cases.
Differentiate pituitary Cushing disease from ectopic ACTH syndrome.
Pituitary adenomas retain some negative feedback sensitivity and will suppress at high steroid doses, whereas ectopic tumors (e.g., small cell lung cancer) typically will not.
5
Perform targeted anatomical imaging based strictly on the biochemical localization.
Image the pituitary gland (or alternative location based on prior steps).
Biochemical proof must precede anatomical imaging to avoid misleading findings from highly prevalent benign incidentalomas.

Key Concept

The diagnostic algorithm for Cushing syndrome rigorously requires biochemical confirmation of hypercortisolism, followed by determination of ACTH dependence, and functional localization before any anatomical imaging is performed.
Estimated Time:2m 0s
Question 524Question →

A 5454-year-old woman with a history of type 22 diabetes mellitus is evaluated in the hospital on day 33 of admission for a liver abscess. She originally presented to the emergency department with a 44-day history of right upper quadrant abdominal pain, high fever, and chills. At that time, an abdominal ultrasound revealed a 6 cm6\text{ cm} fluid collection in the right hepatic lobe. She underwent successful image-guided percutaneous drain placement and was empirically started on intravenous vancomycin, piperacillin-tazobactam, and metronidazole. Today, the patient reports significant improvement in her abdominal pain. Her temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 124/78 mm Hg124/78\text{ mm Hg}, and pulse is 76/min76/\text{min}. The percutaneous drain has minimal purulent output. Both blood cultures and the initial abscess aspirate cultures (aerobic and anaerobic) are now growing pure *Klebsiella pneumoniae*. Susceptibility testing demonstrates the isolate is sensitive to ceftriaxone, cefepime, ciprofloxacin, and piperacillin-tazobactam, and is resistant to ampicillin. Which of the following is the most appropriate next step in pharmacotherapy?

Show answer & explanation

Answer: Discontinue all current antibiotics and initiate intravenous ceftriaxone

Answer

Discontinue all current antibiotics and initiate intravenous ceftriaxone
Primary *Klebsiella pneumoniae* liver abscess is a well-recognized clinical entity, particularly in patients with type 2 diabetes mellitus. Initial management appropriately includes source control (percutaneous drainage) and empiric broad-spectrum antibiotics to cover a potential polymicrobial intra-abdominal infection. However, once clinical improvement is noted and reliable culture data returns showing a pure growth of *K. pneumoniae* sensitive to third-generation cephalosporins, the standard of care dictates de-escalation. Intravenous ceftriaxone provides excellent, targeted coverage for this organism with adequate liver tissue penetration. Continuing vancomycin (Gram-positive coverage), piperacillin-tazobactam (anti-pseudomonal coverage), or metronidazole (anaerobic coverage) is no longer necessary and violates antimicrobial stewardship guidelines.

Step-by-Step Solution

1
Evaluate the clinical status and source control.
The patient is clinically improving (afebrile, normal vitals, decreasing pain) following successful percutaneous drainage of the liver abscess.
Clinical stability and adequate source control are prerequisites for modifying or de-escalating antimicrobial therapy.
2
Analyze the microbiologic culture and susceptibility data.
Cultures show a monomicrobial infection with Klebsiella pneumoniae. The isolate is highly susceptible to narrower-spectrum agents like ceftriaxone.
Culture data dictates the definitive antibiotic choice, allowing the transition from broad empiric coverage to targeted therapy.
3
Apply antimicrobial stewardship principles to adjust the regimen.
Vancomycin (MRSA coverage), piperacillin-tazobactam (Pseudomonal coverage), and metronidazole (anaerobic coverage) can all be safely discontinued in favor of ceftriaxone monotherapy.
De-escalating to the narrowest effective agent prevents the development of multidrug-resistant organisms and minimizes adverse drug events.

Key Concept

Antimicrobial stewardship dictates that empiric broad-spectrum antibiotics should be de-escalated to targeted, narrow-spectrum therapy once culture and susceptibility data become available.
Question 525Question →

A 58-year-old man with a history of alcohol-associated cirrhosis and refractory ascites is evaluated on hospital day 2. He initially presented with progressive confusion, fever, and diffuse abdominal discomfort. Upon admission, his temperature was 38.3∘C38.3^\circ\text{C} (100.9∘F100.9^\circ\text{F}), blood pressure was 102/65 mmHg102/65\text{ mmHg}, and heart rate was 105/min105/\text{min}. Physical examination demonstrated a tense, distended abdomen with shifting dullness and diffuse tenderness, but no guarding or rigidity.

Initial laboratory results from admission:

ParameterValueReference Range
Hemoglobin10.4 g/dL10.4\text{ g/dL}13.5−17.5 g/dL13.5-17.5\text{ g/dL}
Leukocyte count11,200/mm311,200/\text{mm}^34,500−11,000/mm34,500-11,000/\text{mm}^3
Platelets88,000/mm388,000/\text{mm}^3150,000−400,000/mm3150,000-400,000/\text{mm}^3
Total bilirubin4.8 mg/dL4.8\text{ mg/dL}0.1−1.2 mg/dL0.1-1.2\text{ mg/dL}
Blood urea nitrogen34 mg/dL34\text{ mg/dL}8−20 mg/dL8-20\text{ mg/dL}
Serum creatinine1.5 mg/dL1.5\text{ mg/dL} (baseline 0.9 mg/dL0.9\text{ mg/dL})0.6−1.2 mg/dL0.6-1.2\text{ mg/dL}
Serum bicarbonate16 mEq/L16\text{ mEq/L}22−28 mEq/L22-28\text{ mEq/L}

Diagnostic paracentesis performed in the emergency department yielded cloudy fluid with a leukocyte count of 850/mm3850/\text{mm}^3 (85%85\% neutrophils). Total protein in the ascitic fluid was 0.8 g/dL0.8\text{ g/dL}. Ascitic fluid cultures were sent, and the patient was empirically started on intravenous ceftriaxone.

Today, his temperature is 37.4∘C37.4^\circ\text{C} (99.3∘F99.3^\circ\text{F}), blood pressure is 98/62 mmHg98/62\text{ mmHg}, and pulse is 92/min92/\text{min}. He appears less confused. Urine output over the last 24 hours has been 600 mL600\text{ mL}.

Which of the following is the most appropriate additional step in the management of this patient?

Show answer & explanation

Answer: Intravenous albumin infusion

Answer

Intravenous albumin infusion
The correct answer is intravenous albumin infusion. This patient has spontaneous bacterial peritonitis (SBP), diagnosed by an ascitic fluid absolute neutrophil count >250/mm3>250/\text{mm}^3 (calculated as 850×0.85=722/mm3850 \times 0.85 = 722/\text{mm}^3). While third-generation cephalosporins (e.g., ceftriaxone) are the correct empiric antibiotic therapy, this patient is at high risk of developing hepatorenal syndrome (HRS), which occurs in up to 30% of SBP cases. The American Association for the Study of Liver Diseases (AASLD) recommends intravenous albumin (1.5 g/kg1.5\text{ g/kg} on day 1, and 1.0 g/kg1.0\text{ g/kg} on day 3) for SBP patients who meet any of the following criteria: serum creatinine >1.0 mg/dL>1.0\text{ mg/dL}, blood urea nitrogen (BUN) >30 mg/dL>30\text{ mg/dL}, or total bilirubin >4.0 mg/dL>4.0\text{ mg/dL}. This patient meets all three criteria. Albumin expands the intravascular volume, improves renal perfusion, and significantly reduces both the incidence of HRS and overall mortality.

Step-by-Step Solution

1
Diagnose Spontaneous Bacterial Peritonitis (SBP)
The patient has an ascitic fluid absolute neutrophil count > 250/mm³ (850 × 0.85 = 722/mm³).
To confirm the primary infection causing the patient's decompensation.
2
Assess the risk of Hepatorenal Syndrome (HRS)
The patient has markedly elevated BUN (34 mg/dL), creatinine (1.5 mg/dL), and total bilirubin (4.8 mg/dL).
To determine if adjunctive therapies are indicated to prevent acute kidney injury.
3
Apply guideline-based criteria for SBP management
The patient meets criteria for intravenous albumin therapy.
To expand intravascular volume, improve renal perfusion, and decrease the incidence of HRS and mortality.

Key Concept

Patients with spontaneous bacterial peritonitis (SBP) and concurrent evidence of renal dysfunction (Cr > 1.0 mg/dL, BUN > 30 mg/dL) or severe liver disease (Bilirubin > 4.0 mg/dL) require adjunctive intravenous albumin to prevent hepatorenal syndrome.
Question 526Question →

A 68-year-old man is admitted to the hospital with a 3-week history of low-grade fever, fatigue, and progressive dyspnea on exertion. His medical history is significant for hypertension, type 2 diabetes mellitus, and stage 4 chronic kidney disease with a baseline serum creatinine of 2.8 mg/dL. His temperature is 38.2°C (100.8°F), blood pressure is 132/78 mmHg, and heart rate is 96/min. Physical examination reveals a new grade 3/6 holosystolic murmur heard best at the cardiac apex and radiating to the axilla. Small, dark red linear streaks are noted under the nail beds of both hands. A transesophageal echocardiogram demonstrates a 1.2-cm mobile vegetation on the posterior leaflet of the mitral valve with moderate mitral regurgitation. Three sets of blood cultures drawn 12 hours apart all grow *Enterococcus faecalis*. Antimicrobial susceptibility testing shows the isolate is susceptible to ampicillin, vancomycin, daptomycin, linezolid, and high-level gentamicin. Which of the following is the most appropriate definitive intravenous pharmacotherapy for this patient?

Show answer & explanation

Answer: Ampicillin and ceftriaxone

Answer

The most appropriate definitive therapy is the combination of ampicillin and ceftriaxone.
The correct answer is the combination of ampicillin and ceftriaxone. Enterococcus faecalis infective endocarditis strictly requires a bactericidal synergistic therapy regimen for a definitive cure. Traditionally, this was achieved by combining a cell wall-active agent (such as ampicillin) with an aminoglycoside (such as gentamicin). However, aminoglycosides carry a well-documented risk of dose-dependent nephrotoxicity, making them exceptionally hazardous in patients with preexisting severe renal impairment, such as this patient with stage 4 chronic kidney disease. A highly effective, alternative synergistic regimen is double beta-lactam therapy using ampicillin and ceftriaxone. Although enterococci are intrinsically resistant to cephalosporins, ceftriaxone uniquely saturates specific complementary penicillin-binding proteins (PBPs 2 and 3). This synergizes perfectly with ampicillin, which binds PBPs 1, 4, and 5. The dual-binding mechanism achieves complete bactericidal activity equivalent to the ampicillin-gentamicin combination while entirely avoiding the risk of aminoglycoside-induced renal failure.

Step-by-Step Solution

1
Identify the primary diagnosis based on the clinical presentation.
The patient has native valve infective endocarditis caused by Enterococcus faecalis, indicated by subacute fever, a new mitral murmur, splinter hemorrhages, echocardiographic evidence of a vegetation, and positive blood cultures.
Establishing the diagnosis and the responsible pathogen is necessary to guide targeted antimicrobial therapy.
2
Determine the therapeutic requirements for curing enterococcal endocarditis.
Enterococci are uniquely tolerant to cell wall-active agents; therefore, a bactericidal synergistic combination regimen is strictly required for clinical cure.
Monotherapy is purely bacteriostatic against enterococci and will result in clinical failure or relapse.
3
Analyze the patient's specific comorbidities that impact pharmacological choices.
The patient has advanced (stage 4) chronic kidney disease with a significantly elevated baseline creatinine of 2.8 mg/dL.
Severe renal impairment is an absolute contraindication for nephrotoxic medications if safer, equally effective alternatives exist.
4
Select the optimal synergistic regimen that maximizes efficacy while minimizing toxicity.
Ampicillin combined with ceftriaxone is selected over ampicillin combined with gentamicin to prevent aminoglycoside-induced acute kidney injury.
The double beta-lactam regimen provides equivalent synergistic bactericidal activity through complementary binding of penicillin-binding proteins, without the nephrotoxic profile of aminoglycosides.

Key Concept

Treatment of Enterococcus faecalis infective endocarditis in patients with high risk of nephrotoxicity.
Question 527Question →

A 42-year-old woman with a 3-year history of limited cutaneous systemic sclerosis is evaluated in the clinic for progressively worsening episodic finger pain. She describes her fingers turning sharply demarcated white, then blue, and finally red upon exposure to cold temperatures. Recent episodes have become more frequent, lasting up to 30 minutes, and are starting to interfere with her work as a graphic designer. Arrange the following management steps for this patient's vasomotor symptoms in the standard sequential order of escalation, starting with the initial fundamental intervention and ending with advanced salvage therapy for refractory disease.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for escalating therapy in secondary Raynaud phenomenon is: 1) Behavioral modifications, 2) Oral dihydropyridine calcium channel blockers, 3) Oral phosphodiesterase-5 inhibitors, and 4) Intravenous prostanoids or digital sympathectomy.
The management of secondary Raynaud phenomenon in systemic sclerosis is strictly stepwise to balance clinical efficacy with medication side effects and procedural risks. The sequence begins universally with lifestyle and behavioral modifications to mitigate vasospastic triggers. When these are insufficient, oral dihydropyridine calcium channel blockers (CCBs) are the gold standard first-line pharmacologic agents. If the patient experiences refractory symptoms despite optimized CCB therapy, a phosphodiesterase-5 (PDE-5) inhibitor is typically added to synergistically promote vasodilation. Finally, for severe, tissue-threatening ischemia (e.g., impending digital ulceration or gangrene) that fails oral therapies, escalating to intravenous prostanoids or surgical digital sympathectomy is indicated.

Step-by-Step Solution

1
Identify the patient's underlying condition and presenting symptoms.
The patient has secondary Raynaud phenomenon due to limited cutaneous systemic sclerosis.
The classic triphasic color changes (pallor, cyanosis, erythema) triggered by cold in a patient with scleroderma establish the diagnosis.
2
Determine the initial, non-pharmacologic management strategy.
Behavioral modifications.
Before initiating medications with potential systemic side effects, all patients must attempt conservative trigger avoidance.
3
Select the first-line oral pharmacologic agent for persistent symptoms.
Dihydropyridine calcium channel blockers.
These are the most thoroughly validated and widely used oral vasodilators for Raynaud phenomenon.
4
Identify the next logical add-on therapy for refractory symptoms.
Phosphodiesterase-5 (PDE-5) inhibitors.
Agents like sildenafil are used as second-line or adjunctive therapy to further promote smooth muscle relaxation when calcium channel blockers are insufficient.
5
Identify the salvage therapy for severe or tissue-threatening ischemia.
Intravenous prostanoids or digital sympathectomy.
These interventions are reserved for critical cases due to their cost, need for intravenous access, and surgical risks.

Key Concept

The stepwise management of secondary Raynaud phenomenon involves starting with conservative lifestyle modifications, progressing to oral vasodilators (first CCBs, then PDE-5 inhibitors or alternative agents), and reserving intravenous prostanoids or sympathectomy for refractory, tissue-threatening disease.
Question 528Question →

A 28-year-old man is brought to the emergency department with a 3-day history of high fevers, severe fatigue, and a new rash. He has a history of intravenous drug use. His temperature is 39.5°C (103.1°F), blood pressure is 108/60 mm Hg, pulse is 115/min, and respiratory rate is 18/min. Physical examination reveals a loud holosystolic murmur at the left lower sternal border that becomes louder with inspiration. Small, tender, erythematous nodules are present on the palmar surface of his fingertips. The patient appears acutely ill and toxic. Arrange the following diagnostic and management steps in the most appropriate chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence for managing this acutely ill patient with suspected infective endocarditis is: 1) Obtain blood cultures, 2) Initiate empiric antibiotics, 3) Perform a transthoracic echocardiogram, and 4) Narrow antimicrobial therapy based on susceptibilities.
In acute infective endocarditis, the priority is identifying the pathogen while immediately preventing hemodynamic collapse. Therefore, blood cultures must be drawn first to ensure the pathogen is captured before antibiotics suppress bacterial growth. Immediately following the blood draws, empiric broad-spectrum antibiotics are administered. Delaying antibiotics for imaging in an acutely toxic patient increases mortality risk. Once stabilized and treated, a transthoracic echocardiogram is performed to evaluate the valves. Finally, once culture results return (usually 48-72 hours later), the antibiotic regimen is narrowed according to susceptibility data.

Step-by-Step Solution

1
Recognize the clinical presentation of acute infective endocarditis.
The patient has a high fever, a tricuspid regurgitation murmur (holosystolic, increases with inspiration), Osler nodes, and a history of intravenous drug use.
Identifying the acute and toxic nature of the presentation dictates the urgency and specific sequence of the clinical workflow.
2
Determine the first priority in an acutely ill patient with a suspected bloodstream infection.
Obtain multiple sets of blood cultures.
Blood cultures must always be drawn prior to administering antibiotics to maximize the yield of pathogen recovery. This is the cornerstone of infectious disease diagnosis.
3
Decide on the timing of pharmacotherapy.
Initiate empiric intravenous antibiotics immediately after cultures are drawn.
In acute, toxic presentations of endocarditis, antibiotics should not be delayed for imaging or culture results.
4
Select the appropriate imaging modality.
Perform a transthoracic echocardiogram (TTE).
TTE is the initial noninvasive test of choice to evaluate for vegetations, typically ordered while or shortly after initial stabilization and treatment begin.
5
Plan the definitive long-term management.
Narrow the antibiotic therapy once culture and susceptibility data return.
De-escalation of antibiotics is a key principle of antimicrobial stewardship, performed after the pathogen is definitively identified.

Key Concept

Diagnosis and step-wise management of acute infective endocarditis
Question 529Question →

Match each patient's clinical presentation and diagnostic findings with the most appropriate targeted antimicrobial regimen.

Click a left item, then click its matching right item

Items

A 24-year-old pregnant patient at 10 weeks gestation evaluated in the outpatient clinic for an expanding annular rash with central clearing after an Appalachian trail hike.
A 65-year-old male admitted to the cardiovascular intensive care unit with a mechanical aortic valve, presenting with fever and blood cultures growing methicillin-resistant Staphylococcus aureus (MRSA).
A 35-year-old patient with untreated HIV and a CD4 count of 40 cells/mm³ evaluated in the infectious disease clinic for fever, weight loss, and blood cultures yielding Mycobacterium avium complex.
A 52-year-old female in the emergency department with acute pyelonephritis and septic shock; urine culture reveals Escherichia coli resistant to third-generation cephalosporins and aztreonam.

Matches

Show answer & explanation

Answer

The correct matches align the pregnant patient with Lyme disease to amoxicillin, the MRSA prosthetic valve endocarditis to vancomycin/gentamicin/rifampin, the disseminated MAC infection to a macrolide/ethambutol, and the ESBL pyelonephritis to a carbapenem.
Each correct pairing directly matches a complex infectious disease scenario with its definitive, guideline-directed antimicrobial regimen, carefully accounting for resistance mechanisms (ESBL), anatomical challenges (prosthetic biofilms), multidrug necessities (mycobacteria), and host safety factors (pregnancy).

Step-by-Step Solution

1
Identify the underlying pathogen and any host-specific contraindications for the pregnant patient.
Pathogen is Borrelia burgdorferi (Lyme disease). Doxycycline is contraindicated in pregnancy, making amoxicillin the correct choice.
Avoidance of teratogenic effects while ensuring effective clearance of the spirochete.
2
Determine the necessary regimen components for prosthetic valve endocarditis caused by MRSA.
Requires vancomycin for MRSA coverage, rifampin for biofilm penetration, and gentamicin for synergy.
Monotherapy is insufficient to eradicate biofilm-associated staphylococcal infections on foreign bodies.
3
Select the appropriate targeted therapy for disseminated MAC in advanced HIV.
A multi-drug regimen comprising a macrolide (clarithromycin) and ethambutol.
Dual therapy is required to adequately treat mycobacterial infections and prevent the rapid emergence of resistance.
4
Interpret the resistance pattern of the E. coli in the patient with pyelonephritis and septic shock.
The resistance profile is pathognomonic for an ESBL-producing organism, necessitating treatment with a carbapenem like meropenem.
ESBL-producing enterobacteriaceae readily hydrolyze penicillins, most cephalosporins, and aztreonam, making carbapenems the safest and most effective option for severe infections.

Key Concept

Selection of targeted antimicrobial therapy must account for pathogen resistance profiles, biofilm presence, and host-specific contraindications.
Estimated Time:2m 0s
Question 530Question →

A 45-year-old woman is evaluated in the rheumatology clinic and newly diagnosed with highly active, seropositive rheumatoid arthritis (RA). Baseline radiographs reveal early marginal erosions in the metacarpophalangeal joints. Arrange the following clinical steps in the most appropriate chronological order for her long-term management, assuming she exhibits an inadequate response to each successive pharmacological intervention.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Initiate methotrexate → Document failure at 3 months → Perform IGRA screening → Add a TNF inhibitor → Switch to a non-TNF biologic.
The treat-to-target approach for rheumatoid arthritis dictates a strict step-up algorithmic sequence. Initial management relies on conventional synthetic DMARDs, predominantly methotrexate, combined with short-term bridging glucocorticoids. Efficacy must be reassessed after 3 months. If target disease activity is not met, the regimen is escalated, typically by adding a first-line biologic DMARD such as a TNF inhibitor. Crucially, immediately prior to initiating any biologic DMARD, screening for latent tuberculosis with an IGRA is universally mandated to prevent life-threatening reactivation. Finally, if a patient fails to respond adequately to the primary TNF inhibitor, evidence-based guidelines recommend switching to a biologic DMARD utilizing a different mechanism of action, such as an IL-6 inhibitor or anti-CD20 monoclonal antibody.

Step-by-Step Solution

1
Initiate methotrexate with folic acid and bridging glucocorticoids.
First-line conventional synthetic DMARD (csDMARD) therapy is established.
Methotrexate is the standard of care initial therapy for all patients with newly diagnosed, active rheumatoid arthritis.
2
Evaluate disease activity after 3 months.
Failure to achieve low disease activity target is formally documented.
The 'treat-to-target' strategy requires reassessment at 3-6 months to objectively determine if medication escalation is necessary.
3
Perform an interferon-gamma release assay (IGRA).
Patient is screened and cleared for latent tuberculosis.
Latent TB screening is universally mandated before the initiation of any biologic DMARD due to the severe risk of disease reactivation.
4
Add a TNF inhibitor to the current regimen.
Patient is escalated to combination therapy (csDMARD + first-line biologic DMARD).
Addition of a TNF inhibitor is the standard initial biologic escalation step for patients failing methotrexate monotherapy.
5
Switch to an IL-6 receptor antagonist or other non-TNF biologic.
Patient is transitioned to a second-line biologic with a different mechanism.
Secondary loss of efficacy to a TNF inhibitor warrants switching to an agent with a non-TNF mechanism of action.

Key Concept

Sequential Treat-to-Target Management of Rheumatoid Arthritis
Question 531Question →

Emergency medical responders bring a 42-year-old female teacher to the emergency department after she was found profoundly disoriented in her classroom. Her husband reports she has experienced worsening fatigue, diffuse headaches, and nausea over the past three days. She has no significant past medical history and takes no medications. On arrival, her temperature is 38.2°C (100.8°F), blood pressure is 145/90 mmHg, pulse is 112/min, and respirations are 18/min. Physical examination is notable for lethargy, mild scleral icterus, and widespread nonblanching purple pinpoint spots over her lower extremities.

Laboratory studies reveal the following:

ParameterResultReference Range
Hemoglobin7.8 g/dL12.0-16.0 g/dL
Platelets18,000/mm³150,000-400,000/mm³
Leukocytes9,500/mm³4,500-11,000/mm³
Blood urea nitrogen34 mg/dL7-18 mg/dL
Creatinine1.9 mg/dL0.6-1.2 mg/dL
Total bilirubin3.8 mg/dL0.1-1.2 mg/dL
Indirect bilirubin2.9 mg/dL0.1-0.8 mg/dL
Lactate dehydrogenase1,250 U/L100-250 U/L
Prothrombin time12 sec11-15 sec
Activated PTT28 sec25-40 sec
Fibrinogen350 mg/dL150-400 mg/dL

A peripheral blood smear demonstrates numerous fragmented red blood cells. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Initiation of plasma exchange

Answer

The most appropriate next step in management is the initiation of plasma exchange.
The correct action is the initiation of plasma exchange. This patient presents with the classic pentad of Thrombotic Thrombocytopenic Purpura (TTP): fever, altered mental status, thrombocytopenia, acute kidney injury (elevated BUN/Creatinine), and microangiopathic hemolytic anemia (anemia, elevated indirect bilirubin, highly elevated LDH, and schistocytes). TTP is caused by severely decreased activity of the von Willebrand factor (vWF)-cleaving protease ADAMTS13, usually due to an acquired autoantibody. This leads to the formation of ultra-large vWF multimers that shear red blood cells and consume platelets in microthrombi throughout the body. Because it is rapidly fatal without treatment, plasma exchange must be initiated immediately upon clinical suspicion. Plasma exchange removes the autoantibodies and the ultra-large vWF multimers, while concurrently replacing the deficient ADAMTS13 enzyme.

Step-by-Step Solution

1
Analyze the clinical presentation and laboratory results to form a diagnosis.
The patient exhibits the classic pentad of Thrombotic Thrombocytopenic Purpura (TTP): microangiopathic hemolytic anemia (MAHA), severe thrombocytopenia, fever, acute kidney injury, and altered mental status.
Recognizing the constellation of symptoms is essential for identifying microangiopathic disorders.
2
Differentiate the suspected diagnosis from other similar coagulopathies.
The normal prothrombin time (PT), normal activated partial thromboplastin time (aPTT), and normal fibrinogen levels rule out Disseminated Intravascular Coagulation (DIC).
DIC involves the massive consumption of coagulation factors, prolonging PT/aPTT, whereas TTP is primarily an issue of platelet aggregation leaving the coagulation cascade intact.
3
Determine the optimal immediate therapeutic intervention.
Plasma exchange (plasmapheresis) must be initiated immediately without waiting for confirmatory ADAMTS13 laboratory results.
TTP is a medical emergency with a high mortality rate if untreated. Plasma exchange rapidly removes the offending autoantibodies and ultra-large von Willebrand factor multimers while replacing the deficient ADAMTS13 enzyme.

Key Concept

Diagnosis and emergent management of Thrombotic Thrombocytopenic Purpura (TTP)
Question 532Question →

A 42-year-old man with a history of intravenous drug use is brought to the emergency department due to severe lower back pain and an inability to move his legs since this morning. For the past week, he has had worsening back pain and subjective fevers. Today, he also noticed he has been unable to urinate. His temperature is 39.1∘C39.1^\circ\text{C} (102.4∘F102.4^\circ\text{F}), blood pressure is 110/70 mm Hg110/70\text{ mm Hg}, and pulse is 112/min112/\text{min}. Physical examination reveals exquisite point tenderness over the L3-L4 spinous processes. Neurologic examination shows 1/51/5 strength in bilateral lower extremities, decreased sensation below the umbilicus, and absent patellar and Achilles reflexes. Bedside ultrasound reveals 800 mL800\text{ mL} of retained urine.

Arrange the following steps in the most appropriate chronological order for the optimal management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Draw blood cultures -> Initiate empiric antibiotics -> Obtain emergent MRI of the spine -> Perform surgical decompression -> De-escalate to targeted antimicrobial therapy.
This patient has a classic presentation of a spinal epidural abscess (SEA) complicated by acute cauda equina syndrome (paraparesis, saddle anesthesia, urinary retention). The management of SEA with neurologic deficits is a surgical emergency and demands a very specific sequence of interventions. The critical first step is drawing blood cultures, which should ideally never be delayed. Immediately following blood cultures, broad-spectrum empiric antibiotics (covering MRSA and Gram-negatives) must be administered. While obtaining tissue for culture prior to antibiotics is the ideal pathway for stable patients without neurologic compromise, acute cord compression mandates immediate therapy to prevent permanent paralysis. Once antibiotics are infusing, an emergent MRI of the entire spine is required to localize the lesion accurately. This is followed by emergent surgical decompression (e.g., laminectomy) and drainage. Finally, once intraoperative cultures result, the broad-spectrum regimen should be de-escalated to targeted therapy to adhere to antimicrobial stewardship principles.

Step-by-Step Solution

1
Draw two sets of peripheral blood cultures
Maximizes the potential for pathogen identification
Systemic antibiotics rapidly sterilize blood cultures; therefore, cultures must be drawn first, provided it does not cause a significant delay in care.
2
Initiate empiric intravenous vancomycin and cefepime
Broad-spectrum coverage against likely pathogens (e.g., MRSA, Gram-negatives) begins
Acute neurologic deficits necessitate immediate antibiotic administration to salvage neurologic function, superseding the usual preference to hold antibiotics for a tissue biopsy in stable patients.
3
Obtain an emergent magnetic resonance imaging (MRI) of the spine
The epidural abscess is anatomically localized
Surgical planning requires precise delineation of the epidural collection's level and spatial extent.
4
Perform surgical decompression and epidural drainage
Spinal cord pressure is relieved and definitive source control is achieved
Medical therapy alone is insufficient for a large epidural abscess causing acute mechanical cord compression; emergent surgery is required.
5
De-escalate to targeted antimicrobial therapy
Narrow-spectrum, pathogen-specific therapy is established
Once operative cultures return, continuing broad-spectrum antibiotics promotes resistance and toxicity; stewardship principles dictate narrowing coverage.

Key Concept

In patients with suspected spinal epidural abscess presenting with acute neurologic deficits, empiric antibiotics must be administered immediately after blood cultures and before imaging or biopsy to prevent irreversible neurologic injury.
Estimated Time:2m 0s
Question 533Question →

A 68-year-old man with a history of type 2 diabetes mellitus is brought to the emergency department by his family due to a severe headache, fever, and progressive confusion over the past 24 hours. On physical examination, his temperature is 39.2°C (102.6°F), blood pressure is 112/72 mmHg, heart rate is 115/min, and respiratory rate is 18/min. He is lethargic, opens his eyes to pain, and is oriented only to his name. Marked nuchal rigidity is present. There are no focal motor deficits, but fundoscopic examination is limited due to patient noncompliance. Place the following management steps in the most appropriate sequential order.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Obtain peripheral blood cultures, 2) Administer empiric antibiotics and dexamethasone, 3) Perform a CT scan of the head, 4) Perform a lumbar puncture, 5) De-escalate to targeted therapy.
The standard of care for suspected acute bacterial meningitis requires obtaining blood cultures first, followed immediately by empiric intravenous antibiotics and dexamethasone. Because this patient is >60 years old and has an altered level of consciousness, there is a substantial risk of brain herniation if a lumbar puncture is performed in the presence of elevated intracranial pressure. Therefore, a non-contrast CT of the head is indicated before the lumbar puncture. Crucially, antibiotics must not be delayed while awaiting the CT scan or the lumbar puncture. Once the CT clears the patient for safe procedural access, the lumbar puncture is performed. Finally, once cultures and sensitivities return (typically 48-72 hours later), the broad-spectrum regimen is narrowed to targeted therapy.

Step-by-Step Solution

1
Identify the clinical syndrome and immediate life threats.
The patient presents with the classic triad of meningitis (fever, nuchal rigidity, altered mental status).
Rapid recognition dictates the urgency of intervention.
2
Determine the required diagnostic and therapeutic interventions.
The patient requires blood cultures, broad-spectrum antibiotics with steroids, a CT scan, and a lumbar puncture.
These are the standard components of acute bacterial meningitis management.
3
Sequence the interventions based on established clinical guidelines for high-risk patients.
Because the patient has altered mental status and is older than 60, a CT scan is required before the lumbar puncture to prevent brain herniation. However, antibiotics must not be delayed for the CT scan.
Delaying antibiotics increases mortality. Blood cultures take only minutes and should precede antibiotics. Therefore, the sequence must be: Blood cultures -> Antibiotics -> CT -> LP -> Targeted therapy.

Key Concept

In patients with suspected bacterial meningitis who meet criteria for neuroimaging before a lumbar puncture (e.g., altered mental status, age >60, focal neurologic deficit, immunocompromised), blood cultures and empiric antibiotics must be administered prior to the CT scan to prevent fatal delays in therapy.
Estimated Time:1m 30s
Question 534Question →

During a routine primary care appointment, a 7171-year-old woman reports experiencing a severe, right-sided headache for the past two weeks. She describes her scalp as being highly sensitive, noting that it hurts simply to brush her hair. Over the last 4848 hours, she has also developed a deep, cramping pain in her jaw that exclusively occurs when she is eating meals. Earlier this morning, she experienced a frightening episode where the vision in her right eye completely went dark for five minutes before spontaneously returning to normal. Her temperature is 37.7∘C37.7^\circ\text{C} (99.9∘F99.9^\circ\text{F}). Physical examination demonstrates a prominent, thickened right temporal artery that is tender to palpation and lacks a palpable pulse. Point-of-care laboratory testing reveals an erythrocyte sedimentation rate of 105 mm/h105\text{ mm/h}.

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Immediate administration of high-dose corticosteroids

Answer

The most appropriate next step is the immediate administration of high-dose corticosteroids to prevent irreversible vision loss caused by giant cell arteritis.
Giant cell arteritis is a large-vessel vasculitis that most commonly affects branches of the carotid artery in older adults. When inflammation involves the ophthalmic artery, it can cause transient vision loss (amaurosis fugax) which rapidly progresses to permanent blindness if left untreated. The immediate priority is administering high-dose systemic corticosteroids (e.g., intravenous methylprednisolone or high-dose oral prednisone depending on severity) to abruptly halt the inflammatory cascade. While a temporal artery biopsy remains the gold standard for a definitive diagnosis, empirical therapy must be initiated the moment clinical suspicion is established, long before the biopsy is scheduled.

Step-by-Step Solution

1
Analyze the patient's demographic and clinical presentation.
The patient is an elderly woman presenting with a new-onset headache, scalp tenderness, jaw claudication, and a transient episode of monocular vision loss (amaurosis fugax).
Identifying the classic triad of symptoms (headache, jaw claudication, vision changes) in a patient over 50 is essential for recognizing the underlying syndrome.
2
Correlate physical examination and laboratory findings with the clinical syndrome.
The thickened, tender temporal artery without a pulse and a markedly elevated erythrocyte sedimentation rate (105 mm/h105\text{ mm/h}) strongly confirm a state of systemic inflammation localized to the cranial arteries.
These findings solidify the clinical diagnosis of giant cell arteritis (temporal arteritis).
3
Determine the urgency and select the most appropriate initial intervention.
Because the patient has already experienced transient vision loss, she is at imminent risk for irreversible blindness (anterior ischemic optic neuropathy). Therefore, high-dose corticosteroids must be administered immediately.
In giant cell arteritis with ischemic complications, reducing vascular inflammation immediately takes precedence over any diagnostic testing to preserve organ function.

Key Concept

Patients with suspected giant cell arteritis (temporal arteritis), especially those with visual symptoms or jaw claudication, require immediate administration of high-dose systemic corticosteroids to prevent irreversible blindness. Treatment should never be delayed for a temporal artery biopsy.
Question 535Question →

A 62-year-old man presents to the emergency department with a 5-day history of progressively worsening shortness of breath, orthopnea, and lower extremity swelling. He has a 30-pack-year smoking history but quit 5 years ago. He also has a 10-year history of erosive rheumatoid arthritis. His joint symptoms were poorly controlled with methotrexate alone, so etanercept was added 4 months ago, resulting in significant improvement in his joint pain. His other medical conditions include mild depression, for which he takes fluoxetine. Temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 154/92 mm Hg154/92 \text{ mm Hg}, pulse is 108 min−1108 \text{ min}^{-1}, and respirations are 24 min−124 \text{ min}^{-1}. Pulse oximetry on room air shows an oxygen saturation of 91%91\%. Physical examination reveals jugular venous distention. Lung auscultation demonstrates bilateral bibasilar crackles and scattered expiratory wheezes. Cardiac examination reveals tachycardia with a prominent S3 gallop. There is 2+2+ bilateral pitting edema of the lower extremities. Joint examination shows no active synovitis. Laboratory studies show:

Brain natriuretic peptide: 850 pg/mL850 \text{ pg/mL}

Arterial blood gas on room air:
pH:7.49\text{pH}: 7.49
PaCO2:28 mm Hg\text{PaCO}_2: 28 \text{ mm Hg}
PaO2:64 mm Hg\text{PaO}_2: 64 \text{ mm Hg}
HCO3−:21 mEq/L\text{HCO}_3^-: 21 \text{ mEq/L}

Chest radiography reveals cardiomegaly, bilateral alveolar infiltrates, and small bilateral pleural effusions.

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Discontinue etanercept and administer intravenous furosemide

Answer

The most appropriate next step is to discontinue etanercept and administer intravenous furosemide.
This patient with rheumatoid arthritis presents with acute decompensated heart failure, characterized by orthopnea, elevated brain natriuretic peptide, an S3 gallop, jugular venous distention, and pulmonary edema on chest radiography. His heart failure was likely induced by etanercept, a tumor necrosis factor (TNF)-alpha inhibitor. TNF-alpha inhibitors are highly effective disease-modifying antirheumatic drugs (DMARDs) but carry a significant risk of causing new-onset heart failure or exacerbating pre-existing cardiac dysfunction. They are absolutely contraindicated in patients with moderate to severe heart failure. The most appropriate next step in management is to immediately discontinue the offending agent and treat the volume overload with intravenous loop diuretics such as furosemide.

Step-by-Step Solution

1
Analyze the clinical presentation and physical examination findings.
The patient has orthopnea, jugular venous distention, an S3 gallop, and bilateral crackles with wheezing (cardiac asthma).
To differentiate between cardiac, pulmonary, and systemic causes of acute dyspnea.
2
Interpret the diagnostic studies.
Elevated BNP, primary respiratory alkalosis on ABG, and cardiomegaly with pulmonary edema on chest x-ray confirm acute decompensated heart failure.
To confirm the clinical diagnosis and rule out primary pulmonary pathology like a COPD exacerbation or infectious pneumonia.
3
Review the patient's pharmacotherapy history for potential triggers.
The patient was started on etanercept, a tumor necrosis factor (TNF)-alpha inhibitor, 4 months ago.
TNF-alpha inhibitors are a well-documented cause of new-onset heart failure or exacerbation of underlying cardiac dysfunction.
4
Determine the appropriate management.
Discontinue the offending agent (etanercept) and administer loop diuretics (furosemide).
Removal of the trigger and acute diuresis are the mainstays of therapy for biologic-induced acute decompensated heart failure.

Key Concept

Tumor necrosis factor (TNF)-alpha inhibitors (e.g., etanercept, infliximab, adalimumab) can cause new-onset heart failure or exacerbate underlying cardiac dysfunction; they must be discontinued immediately if heart failure develops.
Question 536Question →

An emergency medical services team brings a 7272-year-old man to the acute care clinic due to a three-day history of escalating dyspnea and lower extremity swelling. He reports coughing up clear sputum and finds it difficult to lie flat at night. His past medical history includes chronic obstructive pulmonary disease (COPD), diet-controlled hypertension, and osteoarthritis. Current medications include inhaled tiotropium and as-needed albuterol.

His temperature is 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure is 156/92 mm Hg156/92\text{ mm Hg}, pulse is 108/min108/\text{min}, and respirations are 26/min26/\text{min}. Pulse oximetry shows 87%87\% on room air. Physical examination reveals jugular venous distention up to 9 cm H2O9\text{ cm H}_2\text{O}. Lung auscultation demonstrates bibasilar crackles extending to the mid-lung fields and prolonged expiration with scattered wheezes. Cardiac examination shows a regular, rapid rhythm with an audible S 3_3 gallop. There is 2+2+ pitting edema in both lower extremities.

Laboratory results are as follows:

TestResultReference Range
Leukocyte count8,400/mm38,400/\text{mm}^34,000−11,000/mm34,000-11,000/\text{mm}^3
B-type natriuretic peptide (BNP)1,250 pg/mL1,250\text{ pg/mL}<100 pg/mL<100\text{ pg/mL}
Thyroid-stimulating hormone (TSH)0.2 μU/mL0.2\ \mu\text{U/mL}0.4−4.0 μU/mL0.4-4.0\ \mu\text{U/mL}
Free thyroxine (T4)1.3 ng/dL1.3\text{ ng/dL}0.9−1.7 ng/dL0.9-1.7\text{ ng/dL}
Arterial pH7.307.307.35−7.457.35-7.45
Arterial pCO2_260 mm Hg60\text{ mm Hg}35−45 mm Hg35-45\text{ mm Hg}
Arterial pO2_254 mm Hg54\text{ mm Hg}75−105 mm Hg75-105\text{ mm Hg}
Arterial HCO3−_3^-28 mEq/L28\text{ mEq/L}22−28 mEq/L22-28\text{ mEq/L}

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Intravenous furosemide and supplemental oxygen

Answer

Intravenous furosemide and supplemental oxygen
The patient is experiencing acute decompensated heart failure (ADHF). Despite a history of COPD and the presence of wheezing, the key differentiating factors are the elevated jugular venous pressure, an S3 gallop, profound pitting edema, and a highly elevated BNP level. The wheezing in this context is known as 'cardiac asthma', caused by peribronchial edema. The mainstay of initial therapy for ADHF with volume overload is preload reduction, typically achieved with intravenous loop diuretics (e.g., furosemide) alongside supplemental oxygen or noninvasive positive pressure ventilation to correct hypoxemia.

Step-by-Step Solution

1
Interpret the physical exam and diagnostic findings to establish the primary diagnosis.
The presence of jugular venous distention, an S3 gallop, bibasilar crackles, pitting edema, and a BNP of 1,250 pg/mL indicates acute decompensated heart failure (ADHF).
It is critical to differentiate ADHF from a COPD exacerbation. While the patient has COPD and wheezes, the cardiac findings and BNP firmly point to cardiac asthma and pulmonary edema.
2
Analyze the arterial blood gas and secondary laboratory findings.
The ABG reveals an acute-on-chronic respiratory acidosis (low pH, high pCO2, and mildly elevated bicarbonate). The thyroid panel shows euthyroid sick syndrome (low TSH, normal free T4).
Understanding the acid-base status ensures that treatments exacerbating acidosis (like bicarbonate) are avoided. Recognizing euthyroid sick syndrome prevents unnecessary antithyroid medications.
3
Select the most appropriate acute intervention for the primary diagnosis.
Intravenous furosemide and supplemental oxygen are selected.
Loop diuretics provide rapid preload reduction and diuresis, which relieves the pulmonary congestion driving the patient's respiratory failure.

Key Concept

Diagnosis and acute management of acute decompensated heart failure (ADHF) presenting with cardiac asthma in a patient with comorbid COPD.
Question 537Question →

A 38-year-old man comes to the emergency department due to persistent high fever, drenching sweats, and dark-colored urine. Five days ago, he was evaluated at an urgent care clinic for an expanding, target-shaped erythematous rash on his right calf and a mild headache. The symptoms began a week after a hiking trip in Rhode Island. He was diagnosed with early localized Lyme disease and prescribed oral doxycycline.

Despite adherence to the medication, the rash has faded but his fevers have worsened. Over the past 48 hours, he developed profound fatigue and noticed his eyes appearing yellow. Vital signs show a temperature of 39.4°C (102.9°F), blood pressure of 112/70 mmHg, and heart rate of 115/min. Physical examination is notable for mild scleral icterus. The abdomen is soft, with a spleen tip palpable below the left costal margin.

Laboratory evaluation shows:
- Hemoglobin: 8.6 g/dL
- Platelet count: 88,000/mm³
- Total bilirubin: 3.5 mg/dL
- Direct bilirubin: 0.5 mg/dL
- Lactate dehydrogenase: 720 U/L

A peripheral blood smear reveals intraerythrocytic pleomorphic ring forms. Which of the following is the most appropriate modification to this patient's antimicrobial regimen?

Show answer & explanation

Answer: Continue doxycycline and add atovaquone and azithromycin

Answer

Continue doxycycline and add atovaquone and azithromycin
The correct answer involves continuing the current Lyme disease treatment and adding targeted therapy for babesiosis. This patient's presentation of fever, hemolytic anemia (elevated indirect bilirubin and LDH), thrombocytopenia, and intraerythrocytic ring forms is diagnostic of babesiosis. *Babesia microti* is a parasite transmitted by the *Ixodes scapularis* tick, which is also the vector for *Borrelia burgdorferi* (Lyme disease) and *Anaplasma phagocytophilum* (anaplasmosis). Coinfection is common in endemic areas like the Northeastern United States. While the patient's early localized Lyme disease is being appropriately treated with doxycycline, this antibiotic has no efficacy against *Babesia*. Therefore, a specific anti-parasitic regimen of atovaquone and azithromycin must be added to treat the babesiosis.

Step-by-Step Solution

1
Identify the primary presentation
The patient has clinical signs of hemolytic anemia (jaundice, high indirect bilirubin, high LDH, low hemoglobin) and a peripheral smear showing intraerythrocytic ring forms.
To establish the specific cause of the new and worsening systemic symptoms.
2
Relate findings to the epidemiological context
The patient has a recent history of early localized Lyme disease following a tick bite in Rhode Island, an endemic area for the Ixodes scapularis tick.
To evaluate for potential tick-borne coinfections.
3
Determine the appropriate targeted therapy
The findings are diagnostic of Babesia microti coinfection. Doxycycline covers Lyme disease but not Babesia; therefore, targeted anti-parasitic therapy with atovaquone and azithromycin must be added.
To select the correct, narrow-spectrum treatment indicated by the diagnostic data, avoiding inappropriate broad-spectrum antibiotics.

Key Concept

Patients with tick-borne illnesses from endemic regions can present with coinfections (e.g., Lyme disease and babesiosis). Babesiosis requires targeted therapy with atovaquone and azithromycin, as the standard treatments for Lyme disease (such as doxycycline) are ineffective against Babesia.
Estimated Time:1m 30s
Question 538Question →

During morning rounds, a 64-year-old woman is evaluated on her third hospital day for management of acute pyelonephritis. She initially presented to the emergency department with a temperature of 38.9°C (102.0°F), right-sided flank pain, and persistent emesis. Blood and urine cultures were drawn, and empiric intravenous piperacillin-tazobactam was initiated.

Today, the patient reports feeling much better. Her flank pain has nearly resolved, and she is eating a regular diet without nausea. She has been afebrile for the past 24 hours. Current vital signs are temperature 37.1°C (98.8°F), heart rate 78/min, and blood pressure 118/76 mm Hg.

The admission blood and urine cultures are now finalizing, both demonstrating heavy growth of *Escherichia coli*. The isolate susceptibility report is as follows:

Antimicrobial AgentSusceptibility
AmpicillinResistant
CeftriaxoneSusceptible
CiprofloxacinSusceptible
FosfomycinSusceptible
Piperacillin-tazobactamSusceptible
Trimethoprim-sulfamethoxazoleSusceptible

The patient has no known drug allergies. Her serum creatinine is 0.80.8 mg/dL.

Which of the following is the most appropriate next step in pharmacologic management?

Show answer & explanation

Answer: Transition to oral trimethoprim-sulfamethoxazole

Answer

Transition to oral trimethoprim-sulfamethoxazole
The correct decision is to transition the patient to oral trimethoprim-sulfamethoxazole. This patient was admitted with bacteremic acute pyelonephritis and has rapidly improved on empiric intravenous therapy. Because she has been afebrile for at least 24 hours, is hemodynamically stable, and is tolerating an oral diet, she is an excellent candidate for step-down to oral antibiotics. The goal of antimicrobial stewardship is to utilize the narrowest effective agent with appropriate pharmacokinetics for the site of infection. Trimethoprim-sulfamethoxazole has excellent oral bioavailability and achieves high concentrations in both the serum and renal parenchyma. This choice safely facilitates hospital discharge while avoiding unnecessarily broad antibiotics.

Step-by-Step Solution

1
Assess the patient's clinical trajectory to determine eligibility for intravenous to oral transition.
The patient is afebrile for 24 hours, hemodynamically stable, and tolerating a regular diet.
Meeting these criteria indicates the patient can safely absorb and respond to oral antimicrobial therapy.
2
Evaluate the susceptibility report to identify viable oral step-down options.
The isolate is susceptible to ciprofloxacin, fosfomycin, and trimethoprim-sulfamethoxazole.
Oral step-down requires an agent that is active against the specific pathogen isolated.
3
Select the most appropriate oral agent based on pharmacokinetics and antimicrobial stewardship.
Trimethoprim-sulfamethoxazole is selected.
Fosfomycin lacks adequate renal tissue penetration for pyelonephritis. Ciprofloxacin is excessively broad and carries severe side effect warnings. Trimethoprim-sulfamethoxazole provides excellent tissue penetration with a narrower spectrum.

Key Concept

Antimicrobial stewardship in transitioning from intravenous to oral therapy for complicated urinary tract infections.
Estimated Time:1m 15s
Question 539Question →

A 31-year-old man presents to the emergency department with a 5-week history of productive cough, low-grade fever, drenching night sweats, and a 55-kg (1111-lb) weight loss. He emigrated from an area with high tuberculosis prevalence three years ago and currently resides in a crowded apartment. His temperature is 38.4∘38.4^\circ C (101.1∘101.1^\circ F), blood pressure is 118/76118/76 mm Hg, pulse is 9292/min, and respirations are 2020/min. Oxygen saturation is 96%96\% on room air. Pulmonary examination reveals bronchial breath sounds and crackles in the right upper lung field. A chest radiograph demonstrates a cavitary infiltrate in the right upper lobe.

Arrange the following interventions in the most appropriate chronological order for the management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct management sequence is: 1) Place the patient in a negative-pressure airborne infection isolation room, 2) Collect sputum specimens for AFB smear and culture, 3) Initiate intensive phase therapy with a 4-drug regimen, and 4) De-escalate to a 2-drug continuation phase therapy.
The correct chronological order for managing a patient with highly suspected active pulmonary tuberculosis begins with immediate airborne isolation, followed by diagnostic sampling, initiation of empiric multi-drug therapy, and finally, targeted de-escalation. Immediate placement in a negative-pressure airborne infection isolation room is the critical first step to prevent nosocomial transmission. Once the patient is isolated, diagnostic sputum specimens must be collected before administering any antimicrobials, as therapy can rapidly render cultures negative and preclude necessary drug susceptibility testing. Following specimen collection, standard intensive phase therapy with a 4-drug regimen (isoniazid, rifampin, pyrazinamide, and ethambutol) is initiated to quickly decrease the mycobacterial burden. After completing 2 months of this intensive phase and confirming organism susceptibility, the regimen is de-escalated to a 2-drug continuation phase (isoniazid and rifampin) for an additional 4 months to achieve a definitive cure.

Step-by-Step Solution

1
Address immediate public health and infection control priorities.
Place the patient in a negative-pressure airborne infection isolation room.
Tuberculosis is spread via airborne droplet nuclei. Prompt isolation is mandatory to prevent nosocomial transmission to staff and other vulnerable patients.
2
Determine the necessary diagnostic sequence before initiating pharmacotherapy.
Collect sputum specimens for acid-fast bacilli (AFB) smear, culture, and nucleic acid amplification testing.
Diagnostic specimens must be obtained prior to antimicrobial administration because empiric therapy can rapidly sterilize the sputum, preventing crucial organism isolation and drug susceptibility testing.
3
Select the appropriate initial empiric pharmacologic intervention.
Initiate intensive phase therapy with isoniazid, rifampin, pyrazinamide, and ethambutol.
A 4-drug regimen is required for the initial 2-month intensive phase to rapidly reduce the mycobacterial burden and prevent the emergence of drug resistance.
4
Identify the correct step-down management strategy following the initial treatment phase.
De-escalate to continuation phase therapy with isoniazid and rifampin.
After completing 2 months of intensive therapy and confirming susceptibility, treatment is simplified to a 2-drug continuation phase for an additional 4 months to eradicate remaining persister organisms.

Key Concept

Management sequence of active pulmonary tuberculosis: Airborne isolation, followed by diagnostic specimen collection, initiation of 4-drug intensive therapy, and subsequent de-escalation to 2-drug continuation therapy.
Question 540Question →

A 32-year-old man is brought to the emergency department due to a 3-day history of progressively worsening, severe right upper quadrant abdominal pain and abdominal swelling. Over the past year, he has experienced significant fatigue and several episodes where his urine appeared abnormally dark, particularly upon waking in the morning. His temperature is 37.8∘C37.8^\circ\text{C} (100.0∘F100.0^\circ\text{F}), blood pressure is 112/68 mm Hg112/68 \text{ mm Hg}, and pulse is 108/min108/\text{min}. Physical examination reveals scleral icterus, mildly labored breathing, and a markedly distended abdomen with shifting dullness. There is severe tenderness to palpation in the right upper quadrant. The liver edge is palpable 4 cm4 \text{ cm} below the right costal margin.

Laboratory results are as follows:

TestResultReference Range
Hemoglobin8.5 g/dL8.5 \text{ g/dL}13.5−17.5 g/dL13.5-17.5 \text{ g/dL}
Mean corpuscular volume92 fL92 \text{ fL}80−100 fL80-100 \text{ fL}
Platelet count105,000/mm3105,000/\text{mm}^3150,000−400,000/mm3150,000-400,000/\text{mm}^3
Leukocyte count3,800/mm33,800/\text{mm}^34,500−11,000/mm34,500-11,000/\text{mm}^3
Reticulocyte count8%8\%0.5−1.5%0.5-1.5\%
Total bilirubin5.1 mg/dL5.1 \text{ mg/dL}0.1−1.2 mg/dL0.1-1.2 \text{ mg/dL}
Direct bilirubin0.6 mg/dL0.6 \text{ mg/dL}0.0−0.3 mg/dL0.0-0.3 \text{ mg/dL}
Lactate dehydrogenase1,450 U/L1,450 \text{ U/L}100−250 U/L100-250 \text{ U/L}
Haptoglobin<10 mg/dL<10 \text{ mg/dL}41−165 mg/dL41-165 \text{ mg/dL}

Abdominal duplex ultrasonography shows a prominently enlarged liver with moderate ascites and absent color flow signal within the hepatic veins.

Which of the following therapies directly targets the primary etiology of this patient's current condition?

Show answer & explanation

Answer: Administration of a monoclonal antibody against complement protein C5

Answer

Administration of a monoclonal antibody against complement protein C5
The correct answer is the administration of a monoclonal antibody against complement protein C5 (Eculizumab). This patient's presentation of intravascular hemolysis (anemia, elevated LDH, low haptoglobin, unconjugated hyperbilirubinemia, reticulocytosis), pancytopenia (low platelets, low WBCs), morning hemoglobinuria, and hepatic vein thrombosis (Budd-Chiari syndrome) is highly characteristic of Paroxysmal Nocturnal Hemoglobinuria (PNH). PNH is an acquired clonal hematopoietic stem cell disorder caused by a mutation in the PIGA gene, which leads to a deficiency of glycosylphosphatidylinositol (GPI) anchor proteins (most notably CD55 and CD59). The absence of these regulatory proteins on the cell surface makes red blood cells highly susceptible to complement-mediated destruction. Thrombosis, particularly in atypical sites such as the hepatic, cerebral, or mesenteric veins, is the leading cause of morbidity and mortality in PNH. Eculizumab binds to the terminal complement protein C5, preventing the formation of the membrane attack complex. This effectively halts intravascular hemolysis and significantly reduces the risk of further thrombotic events.

Step-by-Step Solution

1
Analyze the clinical presentation and laboratory findings to identify the primary mechanism of disease.
The patient has severe right upper quadrant pain, hepatomegaly, and ascites. Labs reveal pancytopenia, marked intravascular hemolysis (high LDH, low haptoglobin, unconjugated hyperbilirubinemia, reticulocytosis), and a history of morning dark urine (hemoglobinuria).
Identifying the constellation of findings is essential to narrow the differential diagnosis for acute hepatomegaly with severe anemia.
2
Interpret the diagnostic imaging in the context of the clinical picture.
Abdominal duplex ultrasound shows absent color flow in the hepatic veins, confirming the diagnosis of Budd-Chiari syndrome (hepatic vein thrombosis).
Budd-Chiari syndrome is a life-threatening complication that frequently occurs in the setting of underlying hypercoagulable states, guiding the search for a hematologic disorder.
3
Synthesize the findings of intravascular hemolysis, pancytopenia, and atypical venous thrombosis.
The combination of Coombs-negative intravascular hemolysis, pancytopenia, and intra-abdominal venous thrombosis strongly points to Paroxysmal Nocturnal Hemoglobinuria (PNH).
PNH is a clonal stem cell disorder characterized by a lack of GPI-anchored complement inhibitors (CD55, CD59), leading to unregulated complement-mediated RBC lysis and a highly thrombogenic state.
4
Determine the targeted pharmacotherapy for the identified condition.
Eculizumab, a monoclonal antibody targeting complement protein C5, is the definitive therapy to halt complement-mediated hemolysis and reduce thrombotic risk in PNH.
Blocking the terminal complement cascade prevents the formation of the membrane attack complex, which is the root pathogenesis in PNH.

Key Concept

Paroxysmal Nocturnal Hemoglobinuria (PNH) classic triad (hemolytic anemia, pancytopenia, and venous thrombosis) and its targeted management with C5 complement inhibitors.
PreviousPage 27 / 158Next
Internal Medicine Practice Questions — USMLE Step 2 CK — Page 27 | Examkin